Contact us to learn more about neural organoid and synthetic substrate technologies that offer outstanding relevance, reproducibility, and fit seamlessly into existing drug discovery workflows to enable generation of high quality assay data.
Stem Pharm’s 3D human neural organoid platform features successfully integrated microglia and reflects the complexity of cell types and important cell-to-cell interactions in the developing brain. The organoid platform is particularly suited to study neuroinflammation, and enables Stem Pharm's biopharma partners to explore new disease pathways and mechanisms, identify and validate targets, and test the neuroinflammatory effects of therapeutics using a highly reproducible and relevant human model capable of multiple assay outputs. Stem Pharm's synthetic hydrogel platform consists of a portfolio of engineered PEG-based biomaterials that offer a synthetic alternative to animal-derived substrates for high-value applications. Based on this synthetic hydrogel technology, Stem Pharm has developed pre-coated and sterilized 96-well imaging plates optimized for neural cell cultures. These pre-coated plates improve assay outcomes, increase reproducibility, eliminate the use of animal-derived products, and save customers significant preparation time.
Brands: 3D human neural organoids
Pre-coated synthetic substrate cell culture plates